Why Did Bill Ackman Buy Alphabet Stock?
Bill Ackman has become famous in the investing world for…
Sell
17
TDOC Quote, Financials, Valuation and Earnings
Last price:
$7.11
Seasonality move
:
11.23%
Day range:
$7.06 - $7.27
52-week range:
$6.35 - $15.21
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.48x
P/B ratio:
0.85x
Volume:
2.4M
Avg. volume:
5.3M
1-year change:
-45.99%
Market cap:
$1.3B
Revenue:
$2.6B
EPS (TTM):
-$5.88
Analysts' Opinion
-
Consensus RatingTeladoc Health has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 19 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $10.21, Teladoc Health has an estimated upside of 41.78% from its current price of $7.20.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.00 representing -11.11% downside risk from its current price of $7.20.
Fair Value
-
According to the consensus of 21 analysts, Teladoc Health has 41.78% upside to fair value with a price target of $10.21 per share.
TDOC vs. S&P 500
-
Over the past 5 trading days, Teladoc Health has overperformed the S&P 500 by 0.79% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Teladoc Health does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Teladoc Health revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Teladoc Health reported revenues of $640.5M.
Earnings Growth
-
Teladoc Health has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Teladoc Health reported earnings per share of -$0.28.
Enterprise value:
1.5B
EV / Invested capital:
--
Price / LTM sales:
0.48x
EV / EBIT:
--
EV / Revenue:
0.59x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
8.88x
Price / Operating cash flow:
7.24x
Enterprise value / EBITDA:
15.25x
Gross Profit (TTM):
$1.8B
Return On Assets:
-25.96%
Net Income Margin (TTM):
-38.97%
Return On Equity:
-54.92%
Return On Invested Capital:
-29.77%
Operating Margin:
-6.58%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $2.4B | $2.6B | $2.6B | $660.5M | $640.5M | |
| Gross Profit | $1.7B | $1.8B | $1.8B | $467.1M | $451.6M | |
| Operating Income | -$227.4M | -$210.5M | -$208.8M | -$29.9M | -$42.2M | |
| EBITDA | -$6.8B | $151.4M | -$587M | $81M | $50.3M | |
| Diluted EPS | -$84.74 | -$1.34 | -$5.88 | -$0.17 | -$0.28 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.1B | $1.2B | $1.3B | $1.5B | $1.7B | |
| Total Assets | $17.8B | $17.7B | $4.3B | $4.4B | $3.5B | |
| Current Liabilities | $332.6M | $331M | $399.8M | $420.6M | $941.5M | |
| Total Liabilities | $1.9B | $1.7B | $2B | $2.1B | $2B | |
| Total Equity | $15.9B | $16B | $2.3B | $2.3B | $1.5B | |
| Total Debt | $1.4B | $1.2B | $1.5B | $1.5B | $1.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $189.3M | $350M | $293.7M | $130.1M | $85.9M | |
| Cash From Investing | -$167.7M | -$156.3M | -$124.1M | -$36.5M | -$29.6M | |
| Cash From Financing | $6.5M | $10.9M | $8.3M | -$1.8M | $2.1M | |
| Free Cash Flow | $16.5M | $193.7M | $169.6M | $93.6M | $56.3M | |
TDOC
Sector
Market Cap
$1.3B
$35M
Price % of 52-Week High
47.34%
44.47%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.9%
1-Year Price Total Return
-45.99%
-38.53%
Beta (5-Year)
1.731
0.738
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$6.98
200-day SMA
Sell
Level
$9.13
Bollinger Bands (100)
Sell
Level
7.91 - 11.37
Chaikin Money Flow
Sell
Level
-129.4M
20-day SMA
Sell
Level
$7.31
Relative Strength Index (RSI14)
Sell
Level
41.90
ADX Line
Sell
Level
24.72
Williams %R
Neutral
Level
-50.2924
50-day SMA
Sell
Level
$9.00
MACD (12, 26)
Sell
Level
-0.49
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Sell
Level
-211.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-5.9274)
Sell
CA Score
(Annual)
Level (-1.3955)
Buy
Beneish M-Score
(Annual)
Level (-4.3813)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.1043)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with Better convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
Stock Forecast FAQ
In the current month, TDOC has received 2 Buy ratings 19 Hold ratings, and 0 Sell ratings. The TDOC average analyst price target in the past 3 months is $10.21.
-
Where Will Teladoc Health Stock Be In 1 Year?
According to analysts, the consensus estimate is that Teladoc Health share price will rise to $10.21 per share over the next 12 months.
-
What Do Analysts Say About Teladoc Health?
Analysts are divided on their view about Teladoc Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Teladoc Health is a Sell and believe this share price will drop from its current level to $8.00.
-
What Is Teladoc Health's Price Target?
The price target for Teladoc Health over the next 1-year time period is forecast to be $10.21 according to 21 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 19 analysts rate the stock a Hold.
-
Is TDOC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Teladoc Health is a Hold. 19 of 21 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TDOC?
You can purchase shares of Teladoc Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Teladoc Health shares.
-
What Is The Teladoc Health Share Price Today?
Teladoc Health was last trading at $7.11 per share. This represents the most recent stock quote for Teladoc Health. Yesterday, Teladoc Health closed at $7.20 per share.
-
How To Buy Teladoc Health Stock Online?
In order to purchase Teladoc Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Bill Ackman Buy Brookfield Stock?
Bill Ackman of Pershing Square Capital has made a number…
Why Is Chewy Stock Up — And Will It Keep Climbing?
We are all witnesses to the crazy e-commerce industry boom…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
27
SAIA alert for Apr 28
Saia [SAIA] is down 3.23% over the past day.
Sell
48
APPF alert for Apr 28
AppFolio [APPF] is up 0.99% over the past day.
Sell
15
KNSL alert for Apr 28
Kinsale Capital Group [KNSL] is up 0.78% over the past day.
